+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
BeiGene - logo
PARP Inhibitors Drug Therapy Market by Indication (Breast Cancer, Ovarian Cancer, Pancreatic Cancer), Drug (Niraparib, Olaparib, Rucaparib), Line Of Therapy, Treatment Setting, End User, Distribution Channel, Therapy Type, Patient Age Group - Global Forecast 2025-2030 - Product Thumbnail Image

PARP Inhibitors Drug Therapy Market by Indication (Breast Cancer, Ovarian Cancer, Pancreatic Cancer), Drug (Niraparib, Olaparib, Rucaparib), Line Of Therapy, Treatment Setting, End User, Distribution Channel, Therapy Type, Patient Age Group - Global Forecast 2025-2030

  • Report
  • August 2025
  • 188 Pages
  • Global
From
Conjugated Monoclonal Antibodies Market Report 2025 - Product Thumbnail Image

Conjugated Monoclonal Antibodies Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Combination Antibody Therapy Market by Indication, Product Type, Therapeutic Approach, Treatment Regimen, End User, Distribution Channel - Global Forecast 2025-2030 - Product Thumbnail Image

Combination Antibody Therapy Market by Indication, Product Type, Therapeutic Approach, Treatment Regimen, End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • August 2025
  • 187 Pages
  • Global
From
Oral Cancer Treatment Market by Treatment Type (Chemotherapy, Immunotherapy, Radiation Therapy), Drug Class (Chemotherapeutics, Immunomodulators, Monoclonal Antibodies), End User, Distribution Channel, Stage - Global Forecast 2025-2030 - Product Thumbnail Image

Oral Cancer Treatment Market by Treatment Type (Chemotherapy, Immunotherapy, Radiation Therapy), Drug Class (Chemotherapeutics, Immunomodulators, Monoclonal Antibodies), End User, Distribution Channel, Stage - Global Forecast 2025-2030

  • Report
  • August 2025
  • 189 Pages
  • Global
From
Head & Neck Cancer Drugs Market by Drug Class (Chemotherapy Agents, Immunotherapy, Monoclonal Antibodies), Route Of Administration (Intravenous, Oral, Subcutaneous), Cancer Type, Distribution Channel, End User - Global Forecast 2025-2030 - Product Thumbnail Image

Head & Neck Cancer Drugs Market by Drug Class (Chemotherapy Agents, Immunotherapy, Monoclonal Antibodies), Route Of Administration (Intravenous, Oral, Subcutaneous), Cancer Type, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • August 2025
  • 192 Pages
  • Global
From
Immuno-Oncology Market by Therapy Type (Cancer Vaccines, Cell Therapy, Checkpoint Inhibitors), Indication (Breast Cancer, Colorectal Cancer, Lung Cancer), End User, Line Of Therapy, Mechanism - Global Forecast 2025-2030 - Product Thumbnail Image

Immuno-Oncology Market by Therapy Type (Cancer Vaccines, Cell Therapy, Checkpoint Inhibitors), Indication (Breast Cancer, Colorectal Cancer, Lung Cancer), End User, Line Of Therapy, Mechanism - Global Forecast 2025-2030

  • Report
  • August 2025
  • 184 Pages
  • Global
From
Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030 - Product Thumbnail Image

Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030

  • Report
  • February 2020
  • 360 Pages
  • Global
From
Hereditary Angioedema Therapeutics Market Report 2025 - Product Thumbnail Image

Hereditary Angioedema Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Global PARP Inhibitors Cancer Therapy Market, Price, Dosage & Clinical Pipeline Outlook 2028 - Product Thumbnail Image

Global PARP Inhibitors Cancer Therapy Market, Price, Dosage & Clinical Pipeline Outlook 2028

  • Report
  • May 2022
  • 240 Pages
  • Global
From
Gastrointestinal Stromal Tumor (GIST) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Gastrointestinal Stromal Tumor (GIST) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 155 Pages
  • Global
From
Neuroendocrine Tumors Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Neuroendocrine Tumors Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 157 Pages
  • Global
From
Synthetic Lethality-based Drugs and Targets Market, 2019-2030: Focus on DNA Repair (including PARP Inhibitors) and Other Novel Cellular Pathways - Product Thumbnail Image

Synthetic Lethality-based Drugs and Targets Market, 2019-2030: Focus on DNA Repair (including PARP Inhibitors) and Other Novel Cellular Pathways

  • Report
  • August 2019
  • 488 Pages
  • Global
From
Gallbladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Gallbladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 195 Pages
  • Global
From
Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 4115 Pages
  • Global
From
Gastric Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Gastric Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 1834 Pages
  • Global
From
PD-1/PDL-1 Inhibitor Market - A Global and Regional Analysis: Focus on Epidemiology, Product, and Region - Analysis and Forecast, 2022-2032 - Product Thumbnail Image

PD-1/PDL-1 Inhibitor Market - A Global and Regional Analysis: Focus on Epidemiology, Product, and Region - Analysis and Forecast, 2022-2032

  • Report
  • September 2022
  • 247 Pages
  • Global
From
Peritoneal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Peritoneal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 925 Pages
  • Global
From
AXL Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

AXL Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Brutons Tyrosine Kinase (BTK) Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Brutons Tyrosine Kinase (BTK) Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
Gastric Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Gastric Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 550 Pages
  • Global
From
Loading Indicator